Recommendations for vitamin A supplementation.
Identifieur interne : 001091 ( Main/Merge ); précédent : 001090; suivant : 001092Recommendations for vitamin A supplementation.
Auteurs : David A. Ross [Royaume-Uni]Source :
- The Journal of nutrition [ 0022-3166 ] ; 2002.
Descripteurs français
- KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Besoins nutritifs, Carence en vitamine A (mortalité), Compléments alimentaires, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Infections à VIH (physiopathologie), Nourrisson, Politique nutritionnelle, Prévalence, Réfugiés, Rétinol (administration et posologie).
- MESH :
- administration et posologie : Rétinol.
- mortalité : Carence en vitamine A.
- physiopathologie : Infections à VIH.
- Adolescent, Adulte, Adulte d'âge moyen, Besoins nutritifs, Compléments alimentaires, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Nourrisson, Politique nutritionnelle, Prévalence, Réfugiés.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Vitamin A.
- mortality : Vitamin A Deficiency.
- physiopathology : HIV Infections.
- Adolescent, Adult, Child, Child, Preschool, Dietary Supplements, Female, Humans, Infant, Middle Aged, Nutrition Policy, Nutritional Requirements, Prevalence, Refugees.
Abstract
In all populations where vitamin A deficiency is an important public health problem, prophylactic vitamin A supplements should be given to all infants and young children (0-59 mo), pregnant women and postpartum women within 6 wk after delivery. The efficacy of vitamin A supplementation of young children is one of the best-proven, safest and most cost-effective interventions in international public health. The International Vitamin A Consultative Group (IVACG) also recommends that three 50,000-international unit (IU) doses of vitamin A should be given at the same time as infant vaccines during the first 6 mo of life. Recent kinetic studies have indicated that this regimen will be safe and is necessary to maintain the infant's vitamin A stores, even when the mother is also given 400,000 IU within the first 6 wk after delivery. IVACG will make a decision on whether to recommend prophylactic supplementation of all women of childbearing age when the results of two large trials in Ghana and Bangladesh are available. Active corneal xerophthalmia is always a medical emergency that should be treated with immediate high-dose vitamin A. High-dose vitamin A treatment is also recommended for infants and young children with xerophthalmia, severe malnutrition or measles. Low-dose vitamin A treatment is recommended for women with night blindness and/or Bitot's spots. Given the evidence of the cost-effectiveness of vitamin A supplementation, it is essential that effective vitamin A supplementation programs are made universally available to all populations where vitamin A deficiency is an important public health problem.
PubMed: 12221268
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000902
- to stream PubMed, to step Curation: 000901
- to stream PubMed, to step Checkpoint: 000901
- to stream Ncbi, to step Merge: 000064
- to stream Ncbi, to step Curation: 000064
- to stream Ncbi, to step Checkpoint: 000064
Links to Exploration step
pubmed:12221268Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recommendations for vitamin A supplementation.</title><author><name sortKey="Ross, David A" sort="Ross, David A" uniqKey="Ross D" first="David A" last="Ross">David A. Ross</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases Epidemiology Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom. david.ross@gmx.net</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Infectious Diseases Epidemiology Unit, London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12221268</idno><idno type="pmid">12221268</idno><idno type="wicri:Area/PubMed/Corpus">000902</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000902</idno><idno type="wicri:Area/PubMed/Curation">000901</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000901</idno><idno type="wicri:Area/PubMed/Checkpoint">000901</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000901</idno><idno type="wicri:Area/Ncbi/Merge">000064</idno><idno type="wicri:Area/Ncbi/Curation">000064</idno><idno type="wicri:Area/Ncbi/Checkpoint">000064</idno><idno type="wicri:doubleKey">0022-3166:2002:Ross D:recommendations:for:vitamin</idno><idno type="wicri:Area/Main/Merge">001091</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recommendations for vitamin A supplementation.</title><author><name sortKey="Ross, David A" sort="Ross, David A" uniqKey="Ross D" first="David A" last="Ross">David A. Ross</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases Epidemiology Unit, London School of Hygiene & Tropical Medicine, London, United Kingdom. david.ross@gmx.net</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Infectious Diseases Epidemiology Unit, London School of Hygiene & Tropical Medicine, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><series><title level="j">The Journal of nutrition</title><idno type="ISSN">0022-3166</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Dietary Supplements</term><term>Female</term><term>HIV Infections (physiopathology)</term><term>Humans</term><term>Infant</term><term>Middle Aged</term><term>Nutrition Policy</term><term>Nutritional Requirements</term><term>Prevalence</term><term>Refugees</term><term>Vitamin A (administration & dosage)</term><term>Vitamin A Deficiency (mortality)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Besoins nutritifs</term><term>Carence en vitamine A (mortalité)</term><term>Compléments alimentaires</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Infections à VIH (physiopathologie)</term><term>Nourrisson</term><term>Politique nutritionnelle</term><term>Prévalence</term><term>Réfugiés</term><term>Rétinol (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Vitamin A</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Rétinol</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Vitamin A Deficiency</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Carence en vitamine A</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Child</term><term>Child, Preschool</term><term>Dietary Supplements</term><term>Female</term><term>Humans</term><term>Infant</term><term>Middle Aged</term><term>Nutrition Policy</term><term>Nutritional Requirements</term><term>Prevalence</term><term>Refugees</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Besoins nutritifs</term><term>Compléments alimentaires</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Nourrisson</term><term>Politique nutritionnelle</term><term>Prévalence</term><term>Réfugiés</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In all populations where vitamin A deficiency is an important public health problem, prophylactic vitamin A supplements should be given to all infants and young children (0-59 mo), pregnant women and postpartum women within 6 wk after delivery. The efficacy of vitamin A supplementation of young children is one of the best-proven, safest and most cost-effective interventions in international public health. The International Vitamin A Consultative Group (IVACG) also recommends that three 50,000-international unit (IU) doses of vitamin A should be given at the same time as infant vaccines during the first 6 mo of life. Recent kinetic studies have indicated that this regimen will be safe and is necessary to maintain the infant's vitamin A stores, even when the mother is also given 400,000 IU within the first 6 wk after delivery. IVACG will make a decision on whether to recommend prophylactic supplementation of all women of childbearing age when the results of two large trials in Ghana and Bangladesh are available. Active corneal xerophthalmia is always a medical emergency that should be treated with immediate high-dose vitamin A. High-dose vitamin A treatment is also recommended for infants and young children with xerophthalmia, severe malnutrition or measles. Low-dose vitamin A treatment is recommended for women with night blindness and/or Bitot's spots. Given the evidence of the cost-effectiveness of vitamin A supplementation, it is essential that effective vitamin A supplementation programs are made universally available to all populations where vitamin A deficiency is an important public health problem.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001091 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 001091 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Merge
|type= RBID
|clé= pubmed:12221268
|texte= Recommendations for vitamin A supplementation.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:12221268" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |